The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients

被引：0

作者：

Wan, B. ^{[1
]}

Xu, C. ^{[2
]}

Wang, W. ^{[3
]}

Zhang, X. ^{[1
]}

Zhang, Q. ^{[2
]}

Zhuang, W. ^{[2
]}

Zhu, Y. ^{[4
]}

Huang, Z. ^{[2
]}

Chen, G. ^{[5
]}

Fang, M. ^{[3
]}

Lv, T. ^{[6
]}

Song, Y. ^{[6
]}

机构：

[1] Nanjing Med Univ, Affiliated Jiangning Hosp, Nanjing, Jiangsu, Peoples R China

[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China

[3] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China

[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China

[5] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China

[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China

来源：

关键词：

non-small-cell lung cancer; MDM2; mutation; prognosis;

D O I：

10.1016/j.jtho.2019.08.2101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP1.03-19

引用

页码：S961 / S961

页数：1